# Probiotics for Gallstones in Post-bariatric Surgery Patients

> **NCT06287931** · NA · UNKNOWN · sponsor: **Shandong Linglong Yingcheng Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Bariatric Surgery Candidate
- Gallstone
- Gallstone Attack
- Gastrointestinal Quality of Life Index
- Probiotics

## Interventions

- **DRUG:** Ursodoxycholic acid group
- **DRUG:** Bifidobacterium group

## Key facts

- **NCT ID:** NCT06287931
- **Lead sponsor:** Shandong Linglong Yingcheng Hospital
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06287931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06287931, "Probiotics for Gallstones in Post-bariatric Surgery Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06287931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*